Live Breaking News & Updates on Jb Chemicals Pharmaceuticals Ltd Pharma

Stay updated with breaking news from Jb chemicals pharmaceuticals ltd pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

KKR taps Torrent Pharmaceuticals for JB Pharma stake sale

KKR s stake in JB Pharma is worth Rs 13,767 crore based on the stock s closing price of Rs 1,649.45 last week ....

India , Pharma-indian , Zyg-pharma , Unichem-indian , Max-healthcare-institute-ltd , Torrent-pharmaceuticals-ltd , Cipla-ltd , Jb-chemicals-pharmaceuticals-ltd-pharma , Novartis , Cipla , Glochem-industries , Torrent-pharma

Moneycontrol Selects: Top stories this evening

Our specially curated package of the most interesting articles ....

Mumbai , Maharashtra , India , Canara , Karnataka , Narendra-modi , Canara-bank , Torrent-pharmaceuticals-ltd , Jb-chemicals-pharmaceuticals-ltd-pharma , Torrent-pharmaceuticals , Tata-motors , Union-bank

JB Pharma signs ₹964 crore deal with Novartis; stock rises - The Hindu BusinessLine

JB Pharma signs ₹964 crore deal with Novartis; stock rises - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Novartis-healthcare-private-ltd , Jb-chemicals-pharmaceuticals-ltd-pharma , Facebook , Twitter , Linkedin , Pharmaceuticals-ltd , Novartis-innovative-therapies ,

JB Pharma cuts price of heart failure drug Azmarda by 50 per cent

JB Pharma cuts price of heart failure drug Azmarda by 50 per cent
deccanchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanchronicle.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Telangana , Switzerland , Dilip-singh-rathore , Jb-chemicals-pharmaceuticals-ltd-pharma , Novartis , Pharmaceuticals-ltd , Domestic-business , Jb-pharma , Azmarda

'Heart failure is no longer Life failure' as JB Pharma decreases price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 per cent

Mumbai (Maharashtra) [India], December 5 (ANI/PRNewswire): JB Chemicals & Pharmaceuticals Ltd (JB Pharma), one of the fastest-growing pharmaceutical companies in India, announced a substantial price decrease of approximately 50 per cent for the critical heart failure drug 'Azmarda'. Azmarda, which contains the patented molecule Saccubutril-Valsartan is indicated for Heart failure which ails 8 to 12 million people in the country. After the price reduction, Azmarda (Saccubutril-Valsartan), 50 mg will be available at Rs 39.6 per tablet as compared to Rs 78 per tablet. Commenting on the move, Dilip Singh Rathore, President - Domestic Business, JB Pharma, said, "Being a leading player in the cardiac segment, JB has decided to take the lead in making their Azmarda drug more accessible and affordable for heart failure patients in India. This is in line with our strategy of providing innovative and quality treatment to a larger patient pool at the most affordable price points. ....

South-africa , United-states , Mumbai , Maharashtra , India , Russia , Switzerland , Dilip-singh-rathore , Azmarda-saccubutril-valsartan , Jb-chemicals-pharmaceuticals-ltd-pharma , Novartis , Pharmaceuticals-ltd